Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple Myeloma
NCT06223516
Recruiting
Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer is typically found in the bones and bone marrow (the spongy tissue inside of the bones) and can cause bone pain, fractures, infections, weaker bones, and kidney failure. Treatments are available, but MM can come back (relapsed) or may not get better (refractory) with treatment. This is a study to determine the safety and pharmacokinetics of ABBV-383 in adult participants with relapsed/refractory (R/R) MM. ABBV-383 is an i... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/14/2025
Locations: Mayo Clinic Arizona /ID# 260799, Phoenix, Arizona +14 locations
Conditions: Multiple Myeloma
Register for Updates
Safety and Effectiveness of Cochlear Implantation in an Expanded Adult Population
NCT06293482
Recruiting
This study aims to evaluate the safety and efficacy of cochlear implantation for adults with bilateral sensorineural hearing loss who currently do not meet the FDA-approved indications for cochlear implantation. Following cochlear implantation, participants will complete speech perception assessments and questionnaires over the course of seven visits.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/14/2025
Locations: Barrow Neurological Institute, Phoenix, Arizona +10 locations
Conditions: Hearing Loss, Sensorineural, Hearing Loss, Bilateral
Register for Updates
Establishing Pressures at the EGJ During Diaphragmatic Breathing Using High-resolution Esophageal Manometry
NCT06329583
Recruiting
The goal of this study is to determine which position, maneuvers or combination thereof generates the highest pressure at the EGJ as assessed by high-resolution esophageal manometry and thus greater or more robust contraction of the diaphragm.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/14/2025
Locations: Mayo Clinic, Jacksonville, Florida
Conditions: Gastroesophageal Reflux, Dysphagia, Esophageal Motility Disorders
Register for Updates
Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease
NCT06409130
Recruiting
The study will look at the effects of NNC0194-0499, cagrilintide and semaglutide, on liver damage and alcohol use in participants with alcoholic liver disease. Participants will get NNC0194-0499, semaglutide, cagrilintide or ''dummy" medicine in different treatment combinations. Which treatment participants get is decided by chance. The study will last for about 39 weeks.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/14/2025
Locations: The Institute for Liver Health, Chandler, Arizona +103 locations
Conditions: Alcohol-related Liver Disease
Register for Updates
Retention and Re-Engagement in Treatment for Addiction Following Serious Injection Related Infections (RETAIN)
NCT06489535
Recruiting
This project is a pilot study of an adapted intervention of an existing Opioid Use Disorder (OUD) treatment retention intervention called Recovery Management Checkups (RMC). This intervention has been adapted to better fit the experiences and unique issues of those that have been hospitalized with serious injection related infections (SIRI) based on the findings from a prior qualitative study from the principal investigator. This project plans to test the adapted intervention within a smaller gr... Read More
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
04/14/2025
Locations: Boston Medical Center, Boston, Massachusetts
Conditions: Opioid Use Disorder, Bloodstream Infection, Osteomyelitis, Endocarditis, Septic Arthritis, Epidural Abscess
Register for Updates
A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy
NCT06528093
Recruiting
This study is open to adults with advanced pancreatic cancer for whom previous treatment was not successful or no treatment exists. The purpose of this study is to find the highest dose of BI 765883 that people with advanced pancreatic cancer can tolerate when taken alone or together with chemotherapy. Another purpose is to check whether BI 765883 helps people with advanced pancreatic cancer. In this study, BI 765883 is given to humans for the first time. Participants receive either BI 765883... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/14/2025
Locations: HealthONE, Denver, Colorado +17 locations
Conditions: Pancreatic Ductal Adenocarcinoma
Register for Updates
Phase II Study of RP2 as Immunoprevention in High-Risk Oral Precancerous Disease
NCT06623110
Recruiting
The goal of this study is to understand the safety, tolerability, and potential efficacy of an injected immune therapy called RP2 to treat oral precancer conditions and prevent progression to an oral cancer. The name of the study drug involved in this study is: -RP2 (a genetically modified live Herpes Simplex V-1 strain)
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/14/2025
Locations: Brigham and Women's Hospital, Boston, Massachusetts +1 locations
Conditions: High-Risk Oral Precancerous Disease
Register for Updates
Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis
NCT06656702
Recruiting
This study aims to study the feasibility of psilocybin therapy for patients with Amyotropic Lateral Sclerosis (ALS) with depressed mood. The secondary objective is to assess its impact on depression, quality of life, hopelessness, and functional status in this patient population.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/14/2025
Locations: Johns Hopkins Center for Psychedelic and Consciousness Research, Baltimore, Maryland
Conditions: Amyotrophic Lateral Sclerosis
Register for Updates
A Comparison of Neuromuscular Recruitment in Trained and Untrained Adults
NCT06820658
Recruiting
The objective of the study is to use neurological techniques to obtain quantitative measurements of nervous system control of skeletal muscle activity in adults aged 60-85 who are either long-term resistance exercisers or who are untrained.
Gender:
ALL
Ages:
Between 60 years and 85 years
Trial Updated:
04/14/2025
Locations: Mayo Clinic, Rochester, Minnesota
Conditions: Healthy, Insulin Resistance
Register for Updates
Internet-based Talking About Risk and Adolescent Choices: Health and Emotion Regulation Options
NCT06894277
Recruiting
Using the efficacious iTRAC intervention to enhance emotion regulation competencies as a foundation, this study will create and test iTRAC-HERO to teach emotion regulation skills in the context of sexual health education.
Gender:
ALL
Ages:
Between 12 years and 14 years
Trial Updated:
04/14/2025
Locations: Klein Buendel, Inc., Golden, Colorado
Conditions: Risky Sexual Behavior, Emotion Regulation, Adolescent Behavior
Register for Updates
Randomized Trial of Cold EMR Compared to Hybrid Cold EMR.
NCT06937671
Recruiting
The goal of this randomized clinical trial is to learn if a combination of hot and cold EMR technique is associated with a lower risk of polyp recurrence without increasing the risk of complication when removing large polyps. Participants will undergo EMR and return for a follow-up endoscopy in 3-6 months to check for polyp recurrence.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/14/2025
Locations: Cleveland Clinic Weston, Weston, Florida +1 locations
Conditions: Polyp of Colon, Endoscopic Mucosal Resection
Register for Updates
Food and Microbiome Longitudinal Investigation (FAMiLI)
NCT03293758
Recruiting
The NYU Human Microbiome Study Cohort is designed to improve understanding of the role of human microbiome in health and disease. This study will serve as a critical NYU biorepository resource for research on human genetics and the microbiome in health and disease
Gender:
ALL
Ages:
40 years and above
Trial Updated:
04/14/2025
Locations: New York University School of Medicine, New York, New York
Conditions: Cancer, Cardiovascular Diseases
Register for Updates